HDL biology
CETP-deficient patients show markedly more large HDL particles but fewer small, more anti-atherogenic HDL particles, alongside more atherogenic very small LDL (PLoS One 2018)
Original title: Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency
Comparing nine patients with cholesteryl ester transfer protein deficiency (CETP-D) and nine normolipidemic controls using gel permeation high-performance liquid chromatography, particle numbers of large and medium LDL were significantly lower in CETP-D (0.66-fold and 0.63-fold, respectively; P < 0.001), while the particle number of atherogenic very small LDL was significantly higher (1.36-fold; P = 0.016). Particle numbers of very large and large HDL were markedly higher in CETP-D (19.9-fold and 4.5-fold, respectively; P < 0.001), whereas particle numbers of small and very small HDL, which have more potent anti-atherogenic functions, were significantly lower (0.76-fold and 0.61-fold, respectively; P < 0.001). This first detailed subclass particle-number assessment in CETP-D suggests pro-atherogenic lipoprotein properties despite elevated HDL cholesterol.
Original abstract
Objective: We previously reported that patients with cholesteryl ester transfer protein (CETP) deficiency (CETP-D) have a higher prevalence of atherosclerotic cardiovascular disease, in spite of increased HDL-C levels. However, characterization of HDL in CETP-D has not been well described. Therefore, we examined HDL particle number (PN) rather than HDL-C level.
Approach And Results: Nine patients with CETP-D and 9 normolipidemic subjects were enrolled. We performed gel permeation high-performance liquid chromatography (GP-HPLC) analysis, determined the cholesterol and triglyceride composition of all lipoprotein subclasses, and calculated the PN of each subclass, which consisted of 3 VLDL (large, medium, and small), 4 LDL (large, medium, small, and very small), and 5 HDL (very large, large, medium, small, and very small) subclasses. The PNs of large and medium LDL were significantly lower in CETP-D than that in healthy subjects (0.66- and 0.63-fold decrease, respectively; p<0.001), whereas the PN of very small LDL, which is known to be atherogenic, was significantly higher (1.36-fold increase, p = 0.016). The PNs of very large and large HDL in CETP-D were markedly higher than that in healthy subjects (19.9- and 4.5-fold increase, respectively; p<0.001), whereas the PNs of small and very small HDL, which have more potent anti-atherogenic functions, were significantly lower (0.76- and 0.61-fold decrease, respectively; p<0.001).
Conclusion: We have assessed the PNs of detailed subclasses of patients with CETP-D for the first time. The PN of larger HDL was markedly increased, that of smaller HDL was decreased, and that of very small LDL was increased, suggesting that CETP-D has pro-atherogenic lipoprotein properties.
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.